Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database

BACKGROUND: We assessed the association of dipeptidyl peptidase 4 inhibitors (DPP4i) with hospitalization for heart failure (HF) using the Korean Health Insurance claims database. METHODS: We collected data on newly prescribed sitagliptin, vildagliptin, and pioglitazone between January 1, 2009 and D...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Sunghwan, Seo, Gi Hyeon, Jung, Chang Hee, Kim, Mee-Kyoung, Jin, Sang-Man, Hwang, You-Cheol, Lee, Byung-Wan, Kim, Jae Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483610/
https://www.ncbi.nlm.nih.gov/pubmed/26124995
http://dx.doi.org/10.4093/dmj.2015.39.3.247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483610/
https://www.ncbi.nlm.nih.gov/pubmed/26124995
http://dx.doi.org/10.4093/dmj.2015.39.3.247

Ejemplares similares